Assignee
BioVersys AG
CH·20 granted patents·16 pending applications·24 citations·filing 2014–2025
Top patents by PatentIndex Score
36 records- 0189US11207305B2Antibiotic combination therapiesBioVersys AG·Filed 2020·Granted Dec 28, 2021·2 cites·20 claims
- 0288US11766425B2Antibiotic combination therapiesBioVersys AG·Filed 2021·Granted Sep 26, 2023·1 cites·21 claims
- 0387US10947237B2Antimicrobial compounds and methods of making and using the sameBioVersys AG·Filed 2016·Granted Mar 16, 2021·9 cites·46 claims
- 0486US12403133B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2024·Granted Sep 2, 2025·0 cites·20 claims
- 0584US12257241B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2023·Granted Mar 25, 2025·0 cites·24 claims
- 0682US10815238B2Antimicrobial compounds and methods of making and using the sameBioVersys AG·Filed 2018·Granted Oct 27, 2020·2 cites·1 claims
- 0782US2025360115A1Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2025·Application pending·0 cites
- 0880US11833139B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2022·Granted Dec 5, 2023·0 cites·16 claims
- 0980US10934295B2Antimicrobials and methods of making and using sameBioVersys AG·Filed 2017·Granted Mar 2, 2021·2 cites·17 claims
- 1079US11903934B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2022·Granted Feb 20, 2024·0 cites·10 claims
- 1178US11098047B2Antimicrobials and methods of making and using sameBioVersys AG·Filed 2017·Granted Aug 24, 2021·2 cites·14 claims
- 1278US2025281469A1Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2025·Application pending·0 cites
- 1376US10815237B2Antimicrobials and methods of making and using sameBioVersys AG·Filed 2017·Granted Oct 27, 2020·2 cites·20 claims
- 1472US11351158B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2020·Granted Jun 7, 2022·0 cites·21 claims
- 1571US11344537B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2020·Granted May 31, 2022·0 cites·16 claims
- 1670US12370184B2Antibiotic combination therapiesBioVersys AG·Filed 2023·Granted Jul 29, 2025·0 cites·20 claims
- 1770US12297201B2Substituted pyrrolo[2,3-d]pyrimidines as antimicrobialsBioVersys AG·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 1870US9682079B2Composition for treatment of pathogens that are resistant to tetracyclinesBioVersys AG·Filed 2014·Granted Jun 20, 2017·4 cites·10 claims
- 1969US2024307385A1Novel compoundsBioVersys AG·Filed 2024·Application pending·0 cites
- 2066US11999739B2Antimicrobials methods of making and using the sameBioVersys AG·Filed 2021·Granted Jun 4, 2024·0 cites·16 claims
- 2163US2026098046A1Rifabutin analogs for the treatment of diseaseBioVersys AG·Filed 2023·Application pending·0 cites
- 2262US12234238B2Antimicrobial compounds and methods of making and using the sameBioVersys AG·Filed 2021·Granted Feb 25, 2025·0 cites·17 claims
- 2362US2025213575A18-heterocyclic-3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives as anti-bacterialsBioVersys AG·Filed 2023·Application pending·0 cites
- 2462US2025376472A13-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivativesBioVersys AG·Filed 2023·Application pending·0 cites
- 2561US2023364065A1Antibiotic combination therapiesBioVersys AG·Filed 2022·Application pending·0 cites
- 2661US2025101039A1Rifamycin derivatives for the treatment of diseasesBioVersys AG·Filed 2023·Application pending·0 cites
- 2760US2025051356A1Rifabutin analogs for the treatment of diseaseBioVersys AG·Filed 2022·Application pending·0 cites
- 2860US2025235434A1Rifabutin analogs for the treatment of diseaseBioVersys AG·Filed 2023·Application pending·0 cites
- 2958US2021403473A1Antimicrobial compounds and methods of making and using the sameBioVersys AG·Filed 2019·Application pending·0 cites
- 3055US2024239800A1Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compoundsBioVersys AG·Filed 2019·Application pending·0 cites
- 3149US2021147422A1Antimicrobials and methods of making and using sameBioVersys AG·Filed 2018·Application pending·0 cites
- 3248US12509462B23-(phenylsulfonyl)-[1,2,3]triazolo[1,5A]quinazolin-5(4H)-one derivativesBioVersys AG·Filed 2019·Granted Dec 30, 2025·0 cites·18 claims
- 3345US12152031B2Biodefense agentsBioVersys AG·Filed 2019·Granted Nov 26, 2024·0 cites·29 claims
- 3445US2025360114A1Intravenous rifabutin formulation and methods of makingBioVersys AG·Filed 2025·Application pending·0 cites
- 3543US2021253589A1Aminomethylamidine and methylamidine antimicrobial compoundsBioVersys AG·Filed 2019·Application pending·0 cites
- 3643US2021222181A1Bacterial vectors for genetic manipulation of bacteriaBioVersys AG·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →